Literature DB >> 31028527

Renin-angiotensin system research: from molecules to the whole body.

Eriko Takimoto-Ohnishi1,2, Kazuo Murakami3.   

Abstract

Hypertension is one of the most important risk factors and a leading cause of death from cardiovascular and cerebrovascular diseases. Based on numerous previous studies, hypertension is thought to be caused by the complex mutual interactions of genetic factors and environmental factors, such as excessive salt intake and stress. However, its detailed mechanisms are not yet clearly understood. The renin-angiotensin system (RAS) is a key hormonal system in the pathogenesis of hypertension. New knowledge is still accruing on this cascade, even after more than 120 years since the discovery of renin. To clarify the molecular mechanisms of RAS in vivo, we created transgenic mice with chronic hypertension. These mice carry the human genes encoding renin, a hypertensive enzyme, and its substrate angiotensinogen. Hypotensive mice homozygous for a targeted disruption of the angiotensinogen gene were also created. This review presents our 47-year history of RAS research.

Entities:  

Keywords:  Angiotensinogen; Hypertension; Knockout mice; Renin; Renin–angiotensin system; Transgenic mice

Mesh:

Substances:

Year:  2019        PMID: 31028527     DOI: 10.1007/s12576-019-00679-4

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  30 in total

1.  Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.

Authors:  A Fukamizu; S Takahashi; M S Seo; M Tada; K Tanimoto; S Uehara; K Murakami
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

2.  Impaired blood-brain barrier function in angiotensinogen-deficient mice.

Authors:  Y Kakinuma; H Hama; F Sugiyama; K Yagami; K Goto; K Murakami; A Fukamizu
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

3.  Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice.

Authors:  K Yanai; T Saito; Y Kakinuma; Y Kon; K Hirota; K Taniguchi-Yanai; N Nishijo; Y Shigematsu; H Horiguchi; Y Kasuya; F Sugiyama; K i Yagami; K Murakami; A Fukamizu
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen.

Authors:  E Takimoto; J Ishida; F Sugiyama; H Horiguchi; K Murakami; A Fukamizu
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

5.  Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.

Authors:  F Sugiyama; S Haraoka; T Watanabe; N Shiota; K Taniguchi; Y Ueno; K Tanimoto; K Murakami; A Fukamizu; K Yagami
Journal:  Lab Invest       Date:  1997-06       Impact factor: 5.662

6.  Structure of the human renin gene.

Authors:  H Miyazaki; A Fukamizu; S Hirose; T Hayashi; H Hori; H Ohkubo; S Nakanishi; K Murakami
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Reduction of depressive-like behavior in mice lacking angiotensinogen.

Authors:  S Okuyama; T Sakagawa; F Sugiyama; A Fukamizu; K Murakami
Journal:  Neurosci Lett       Date:  1999-02-19       Impact factor: 3.046

8.  Angiotensinogen-deficient mice with hypotension.

Authors:  K Tanimoto; F Sugiyama; Y Goto; J Ishida; E Takimoto; K Yagami; A Fukamizu; K Murakami
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

Review 9.  Updated national and international hypertension guidelines: a review of current recommendations.

Authors:  Sverre Kjeldsen; Ross D Feldman; Liu Lisheng; Jean-Jacques Mourad; Chern-En Chiang; Weizhong Zhang; Zhaosu Wu; Wei Li; Bryan Williams
Journal:  Drugs       Date:  2014-11       Impact factor: 9.546

Review 10.  Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.

Authors:  Natalia Muñoz-Durango; Cristóbal A Fuentes; Andrés E Castillo; Luis Martín González-Gómez; Andrea Vecchiola; Carlos E Fardella; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2016-06-23       Impact factor: 5.923

View more
  11 in total

1.  Evaluation of Active Renin Concentration in A Cohort of Adolescents with Primary Hypertension.

Authors:  Anna Deja; Piotr Skrzypczyk; Magdalena Nowak; Małgorzata Wrońska; Michał Szyszka; Anna Ofiara; Justyna Lesiak-Kosmatka; Anna Stelmaszczyk-Emmel; Małgorzata Pańczyk-Tomaszewska
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

2.  Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition.

Authors:  Qun Yu; Dewei Zhu; Yang Zou; Kai Wang; Peili Rao; Yunhui Shen
Journal:  Front Med (Lausanne)       Date:  2022-05-24

3.  COVID-19, Angiotensin Receptor Blockers, and the Brain.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2020-05-08       Impact factor: 5.046

4.  Chronic administration of pharmacological doses of angiotensin 1-7 and iodoangiotensin 1-7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats.

Authors:  Filipe F Stoyell-Conti; Alesa Chabbra; Joseph Puthentharayil; Katya Rigatto; Robert C Speth
Journal:  Physiol Rep       Date:  2021-04

Review 5.  Severity of COVID-19 and Treatment Strategy for Patient With Diabetes.

Authors:  Shi Jin; Weina Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

6.  Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study.

Authors:  Faris Lami; Maisa Elfadul; Hiba Rashak; Mohannad Al Nsour; Hashaam Akhtar; Yousef Khader; Ahmed M Hussein; Mariam Naciri; Sahar Samy; Yasser Ghaleb; Hana Taha; Alaa Hussein; Nameer A Ali; Raheem Hussein; Aamer Ikram; Fazal Ur Rahman; Mohammad Mujeeb Khan; Reema Adam; Abdulrazaq Yusuf Ahmed; Salma Afifi
Journal:  JMIR Public Health Surveill       Date:  2022-03-15

7.  Sustained Downregulation of Vascular Smooth Muscle Acta2 After Transient Angiotensin II Infusion: A New Model of "Vascular Memory".

Authors:  Lucie Pothen; Roxane Verdoy; Delphine De Mulder; Hrag Esfahani; Charlotte Farah; Lauriane Y M Michel; Flavia Dei Zotti; Bertrand Bearzatto; Jerome Ambroise; Caroline Bouzin; Chantal Dessy; Jean-Luc Balligand
Journal:  Front Cardiovasc Med       Date:  2022-03-14

8.  Higher plasma renin activity is associated with increased kidney damage risk in patients with hypertension and glucose metabolic disorders.

Authors:  Mengyue Lin; Mulalibieke Heizhati; Lin Gan; Jing Hong; Ting Wu; Zuhere Xiamili; Ling Tong; Yue Lin; Nanfang Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-05-06       Impact factor: 2.885

9.  COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?

Authors:  Federica Francescangeli; Maria Laura De Angelis; Marta Baiocchi; Rachele Rossi; Mauro Biffoni; Ann Zeuner
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

Review 10.  ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.

Authors:  Federica Saponaro; Grazia Rutigliano; Simona Sestito; Lavinia Bandini; Barbara Storti; Ranieri Bizzarri; Riccardo Zucchi
Journal:  Front Mol Biosci       Date:  2020-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.